Courtesy of Benzinga.
- Ocera Therapeutics Inc (NASDAQ: OCRX) shares dropped 68.3 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy.
- Regulus Therapeutics Inc (NASDAQ: RGLS) shares declined 50 percent to $1.12 after the company received a written communication from the U.S. Food and Drug Administration that the clinical development for the company’s RG-101 remains on clinical hold.
- Pulmatrix Inc (NASDAQ: PULM) declined 27.9 percent to $2.43 after surging 51.80 percent on Friday. Pulmatrix reported a $5 million registered direct offering.
- Tempur Sealy International Inc (NYSE: TPX) shares dipped 27.6 percent to $45.74 following announcement of termination of Mattress Firm (NASDAQ: MFRM) contracts.
- Opus Bank (NASDAQ: OPB) fell 23.9 percent to $20.75. Opus Bank reported a Q4 loss of $0.55 per share.
- Rite Aid Corporation (NYSE: RAD) dropped 16.4 percent to $5.79. In a merger amendment publicized Monday morning, Walgreens Boots Alliance Inc (NASDAQ: WBA) and Rite Aid agreed to reduce the value of Rite Aid shares between $6.50 and $7 and to divest a total of 1,200 stores. The initial agreement proposed a divestment of 1,000. The companies also announced the extension of the transaction deadline to July 31.
- Rewalk Robotics Ltd (NASDAQ: RWLK) fell 13 percent to $2.00. Rewalk Robotics shares have declined 77.02 percent over the past 52 weeks, while the S&P 500 index has gained 18.32 percent in the same period.
- Fitbit Inc (NYSE: FIT) shares tumbled 12.1 percent to $6.34 after the company surprised investors with a downward revision to its fourth-quarter guidance and a plan to slash around 6 percent of its total workforce.
- Costamare Inc (NYSE: CMRE) declined 10.3 percent to $5.39. Credit Suisse downgraded Costamare from Neutral to Underperform.
- Globus Maritime Ltd (NASDAQ: GLBS) shares dropped 10 percent to $8.48 after rising 3.51 percent on Friday.
- Enbridge Energy Partners, L.P. (NYSE: EEP) declined 9.4 percent to $19.33. Mizuho downgraded Enbridge Energy Partners from Buy to Neutral and lowered the price target from $29.00 to $22.00.
- Booz Allen Hamilton Holding Corporation (NYSE: BAH) dropped 8.3 percent to $33.25 after the company reported weaker-than-expected earnings for its third quarter.
- Array Biopharma Inc (NASDAQ: ARRY) declined 7.3 percent to $10.38. Leerink Swann downgraded Array Biopharma from Outperform to Market Perform.
- FibroGen Inc (NASDAQ: FGEN) fell 6.7 percent to $21.75. FibroGen disclosed that FG-4592 has met primary endpoints in two Phase 3 anemia studies in China.
- Rowan Companies PLC (NYSE: RDC) slipped 6.5 percent to $18.02. Jefferies downgraded Rowan from Buy to Hold.
- CONSOL Energy Inc. (NYSE: CNX) dropped 6 percent to $17.86. SunTrust Robinson Humphrey downgraded CONSOL Energy from Buy to Hold.
- Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) shares fell 5.2 percent to $5.13. Baird downgraded Himax from Outperform to Neutral.
- Novan Inc (NASDAQ: NOVN) dropped 4.8 percent to $4.62 after dipping 74.01 percent on Friday.
- Paycom Software Inc (NYSE: PAYC) declined 4.6 percent to $46.94. Pacific Crest downgraded Paycom Software from Overweight to Sector Weight.
- Barclays PLC (ADR) (NYSE: BCS) fell 3 percent to $11.18. Berenberg downgraded Barclays from Hold to Sell.
Latest Ratings for OCRX
Date | Firm | Action | From | To |
---|---|---|---|---|
Dec 2016 | H.C. Wainwright | Initiates Coverage On | Buy | |
Nov 2016 | Aegis Capital | Initiates Coverage On | Buy | |
Feb 2016 | Brean Capital | Initiates Coverage on | Buy |
View More Analyst Ratings for OCRX
View the Latest Analyst Ratings
Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings